Literature DB >> 26796690

A Primary Role for Nucleus Accumbens and Related Limbic Network in Vocal Tics.

Kevin W McCairn1, Yuji Nagai2, Yukiko Hori2, Taihei Ninomiya3, Erika Kikuchi2, Ju-Young Lee4, Tetsuya Suhara2, Atsushi Iriki5, Takafumi Minamimoto2, Masahiko Takada6, Masaki Isoda7, Masayuki Matsumoto8.   

Abstract

Inappropriate vocal expressions, e.g., vocal tics in Tourette syndrome, severely impact quality of life. Neural mechanisms underlying vocal tics remain unexplored because no established animal model representing the condition exists. We report that unilateral disinhibition of the nucleus accumbens (NAc) generates vocal tics in monkeys. Whole-brain PET imaging identified prominent, bilateral limbic cortico-subcortical activation. Local field potentials (LFPs) developed abnormal spikes in the NAc and the anterior cingulate cortex (ACC). Vocalization could occur without obvious LFP spikes, however, when phase-phase coupling of alpha oscillations were accentuated between the NAc, ACC, and the primary motor cortex. These findings contrasted with myoclonic motor tics induced by disinhibition of the dorsolateral putamen, where PET activity was confined to the ipsilateral sensorimotor system and LFP spikes always preceded motor tics. We propose that vocal tics emerge as a consequence of dysrhythmic alpha coupling between critical nodes in the limbic and motor networks. VIDEO ABSTRACT.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26796690     DOI: 10.1016/j.neuron.2015.12.025

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  21 in total

1.  Differentiating tic electrophysiology from voluntary movement in the human thalamocortical circuit.

Authors:  Jackson N Cagle; Michael S Okun; Enrico Opri; Stephanie Cernera; Rene Molina; Kelly D Foote; Aysegul Gunduz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-05       Impact factor: 10.154

2.  The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

Authors:  Bekir B Artukoglu; Michael H Bloch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 3.  The neurobiology of innate, volitional and learned vocalizations in mammals and birds.

Authors:  Andreas Nieder; Richard Mooney
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-11-18       Impact factor: 6.237

Review 4.  A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation Outcomes.

Authors:  Joshua K Wong; Erik H Middlebrooks; Sanjeet S Grewal; Leonardo Almeida; Christopher W Hess; Michael S Okun
Journal:  Mov Disord       Date:  2020-04-12       Impact factor: 10.338

Review 5.  Tourette syndrome: a disorder of the social decision-making network.

Authors:  Roger L Albin
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

6.  Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome.

Authors:  Daniele Caligiore; Francesco Mannella; Michael A Arbib; Gianluca Baldassarre
Journal:  PLoS Comput Biol       Date:  2017-03-30       Impact factor: 4.475

Review 7.  Putting the Pieces Together in Gilles de la Tourette Syndrome: Exploring the Link Between Clinical Observations and the Biological Basis of Dysfunction.

Authors:  Rowshanak Hashemiyoon; Jens Kuhn; Veerle Visser-Vandewalle
Journal:  Brain Topogr       Date:  2016-10-25       Impact factor: 3.020

8.  Animal Models of Tourette Syndrome-From Proliferation to Standardization.

Authors:  Dorin Yael; Michal Israelashvili; Izhar Bar-Gad
Journal:  Front Neurosci       Date:  2016-03-31       Impact factor: 4.677

Review 9.  Tourette syndrome research highlights from 2016.

Authors:  Kevin J Black
Journal:  F1000Res       Date:  2017-08-11

10.  Aripiprazole Selectively Reduces Motor Tics in a Young Animal Model for Tourette's Syndrome and Comorbid Attention Deficit and Hyperactivity Disorder.

Authors:  Francesca Rizzo; Ester Nespoli; Alireza Abaei; Izhar Bar-Gad; Dinesh K Deelchand; Jörg Fegert; Volker Rasche; Bastian Hengerer; Tobias M Boeckers
Journal:  Front Neurol       Date:  2018-02-13       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.